The expression of cytokeratin and transthyretin by tumor cells and the lack of GFAP expression differentiated this tumor from ependymoma, and the co-expression of cytokeratin, S-100 protein and vimentin with negative CEA was helpful in distinguishing it from metastatic carcinoma [13]. This evidence concerns the gene CEACAM5 and neoplasm.